Guo Lu

Guo Lu

Auto-generated profile, based on publicly available information

Guo Lu

Dezhou People's Hospital, Department of Neurology, Dezhou, Shandong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
GLGuo Lu
Guo Lu
WLWeihong Liu
Weihong Liu
XHXinying Huang
Xinying Huang
YZYanxin Zhao
Yanxin Zhao
Many factors are found to express abnormally in AD patients or animals, such as tumor necrosis factor (TNF)-α8, brain-derived neurotrophic factor (BDNF)9, homocysteine10, and C-reactive protein (CRP)11. BDNF and CRP are both widely studied factors in AD development. Lower BDNF levels were found in AD patients, higher BDNF serum levels were correlated with slower cognitive decline in AD patients12. For CRP, lower levels of CRP were observed in AD patients than the healthy13. Besides, among the factors, the human complement factor H (CFH), which is considered to play an important role in the stimulation of pro-inflammatory responses, has been noticed in AD development14,15. Animal researches showed CFH was down-regulated in AD models16; however in clinical studies, the results are still controversial17. Some researches indicate CFH is abnormally expressed in AD, however others showed no significant difference was found15,18. Similar dispute is also found in levels of CRP. Despite the findings that CRP was decreased in AD patients, a recent study provided opposite results19,20.